Literature DB >> 24685176

Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes.

Soyon Hong1, Beth L Ostaszewski2, Ting Yang2, Tiernan T O'Malley3, Ming Jin2, Katsuhiko Yanagisawa4, Shaomin Li2, Tim Bartels2, Dennis J Selkoe5.   

Abstract

Soluble Aβ oligomers contribute importantly to synaptotoxicity in Alzheimer's disease, but their dynamics in vivo remain unclear. Here, we found that soluble Aβ oligomers were sequestered from brain interstitial fluid onto brain membranes much more rapidly than nontoxic monomers and were recovered in part as bound to GM1 ganglioside on membranes. Aβ oligomers bound strongly to GM1 ganglioside, and blocking the sialic acid residue on GM1 decreased oligomer-mediated LTP impairment in mouse hippocampal slices. In a hAPP transgenic mouse model, substantial levels of GM1-bound Aβ₄₂ were recovered from brain membrane fractions. We also detected GM1-bound Aβ in human CSF, and its levels correlated with Aβ₄₂, suggesting its potential as a biomarker of Aβ-related membrane dysfunction. Together, these findings highlight a mechanism whereby hydrophobic Aβ oligomers become sequestered onto GM1 ganglioside and presumably other lipids on neuronal membranes, where they may induce progressive functional and structural changes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24685176      PMCID: PMC4129520          DOI: 10.1016/j.neuron.2014.02.027

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  70 in total

1.  Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

Authors:  Victor L Villemagne; Keyla A Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.

Authors:  Takami Tomiyama; Shogo Matsuyama; Hiroyuki Iso; Tomohiro Umeda; Hiroshi Takuma; Kiyouhisa Ohnishi; Kenichi Ishibashi; Rie Teraoka; Naomi Sakama; Takenari Yamashita; Kazuchika Nishitsuji; Kazuhiro Ito; Hiroyuki Shimada; Mary P Lambert; William L Klein; Hiroshi Mori
Journal:  J Neurosci       Date:  2010-04-07       Impact factor: 6.167

3.  High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.

Authors:  Hiroaki Fukumoto; Takahiko Tokuda; Takashi Kasai; Noriko Ishigami; Hiroya Hidaka; Masaki Kondo; David Allsop; Masanori Nakagawa
Journal:  FASEB J       Date:  2010-03-25       Impact factor: 5.191

Review 4.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

5.  Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

Authors:  Anne M Fagan; Denise Head; Aarti R Shah; Daniel Marcus; Mark Mintun; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

6.  Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.

Authors:  Shugui Chen; Satya P Yadav; Witold K Surewicz
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

7.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40).

Authors:  Nouara Yahi; Anaïs Aulas; Jacques Fantini
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 9.  Biomarkers of Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Anne M Fagan; David M Holtzman
Journal:  Neurobiol Dis       Date:  2008-10-28       Impact factor: 5.996

10.  Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.

Authors:  Wei-Qin Zhao; Francesca Santini; Robert Breese; Dave Ross; Xiaohua Douglas Zhang; David J Stone; Marc Ferrer; Matthew Townsend; Abigail L Wolfe; Matthew A Seager; Gene G Kinney; Paul J Shughrue; William J Ray
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

View more
  71 in total

1.  A Robust and Scalable High-Throughput Compatible Assay for Screening Amyloid-β-Binding Compounds.

Authors:  Richard McClure; Rey Redha; Paige Vinson; Wellington Pham
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

Review 3.  Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Authors:  Tien-Phat V Huynh; Albert A Davis; Jason D Ulrich; David M Holtzman
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

4.  What Is the "Relevant" Amyloid β42 Concentration?

Authors:  Jevgenij A Raskatov
Journal:  Chembiochem       Date:  2019-05-17       Impact factor: 3.164

5.  Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.

Authors:  David C Bode; Mark D Baker; John H Viles
Journal:  J Biol Chem       Date:  2016-12-07       Impact factor: 5.157

6.  Rapid regulation of sialidase activity in response to neural activity and sialic acid removal during memory processing in rat hippocampus.

Authors:  Akira Minami; Yuko Meguro; Sayaka Ishibashi; Ami Ishii; Mako Shiratori; Saki Sai; Yuuki Horii; Hirotaka Shimizu; Hokuto Fukumoto; Sumika Shimba; Risa Taguchi; Tadanobu Takahashi; Tadamune Otsubo; Kiyoshi Ikeda; Takashi Suzuki
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 7.  GM1 ganglioside and Alzheimer's disease.

Authors:  Katsuhiko Yanagisawa
Journal:  Glycoconj J       Date:  2015-04-23       Impact factor: 2.916

Review 8.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

9.  Toxic HypF-N Oligomers Selectively Bind the Plasma Membrane to Impair Cell Adhesion Capability.

Authors:  Reinier Oropesa-Nuñez; Sandeep Keshavan; Silvia Dante; Alberto Diaspro; Benedetta Mannini; Claudia Capitini; Cristina Cecchi; Massimo Stefani; Fabrizio Chiti; Claudio Canale
Journal:  Biophys J       Date:  2018-03-27       Impact factor: 4.033

Review 10.  New insights on the role of microglia in synaptic pruning in health and disease.

Authors:  Soyon Hong; Lasse Dissing-Olesen; Beth Stevens
Journal:  Curr Opin Neurobiol       Date:  2015-12-30       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.